Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Finasteride: a clinical review

G J Gormley1

  • 1Merck Research Laboratories, Rahway, NJ 07065-0914, USA.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Finasteride, a 5 alpha-reductase inhibitor, selectively lowers dihydrotestosterone (DHT) to treat enlarged prostates and male pattern baldness. It preserves testosterone levels, maintaining muscle, bone, and sexual function benefits.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The importance of human factors in right-left errors.

Anaesthesia·2018
Same author

Living with 'melanoma' … for a day: a phenomenological analysis of medical students' simulated experiences.

The British journal of dermatology·2017
Same author

Implications of aligning full registration of doctors with medical school graduation: a qualitative study of stakeholder perspectives.

BMJ open·2016
Same author

Non-steroidal anti-inflammatory drug use and cervical cancer risk: a case-control study using the Clinical Practice Research Datalink.

Cancer epidemiology·2013
Same author

Dyspepsia.

BMJ (Clinical research ed.)·2011
Same author

The use of real patients in OSCEs: a survey of medical students’ predictions and opinions.

Medical teacher·2011

Area of Science:

  • Pharmacology
  • Andrology
  • Urology

Background:

  • Finasteride represents a novel class of 5 alpha-reductase inhibitors.
  • It selectively targets dihydrotestosterone (DHT) in specific organs like the prostate and scalp.
  • Circulating testosterone levels remain unaffected, preserving androgen-mediated effects.

Purpose of the Study:

  • To evaluate the efficacy of finasteride in managing benign prostatic hyperplasia (BPH).
  • To explore the potential of finasteride in prostate cancer prevention.
  • To assess its role in treating male pattern baldness.

Main Methods:

  • Administration of finasteride to patients with enlarged prostate glands.
  • Long-term data collection on disease progression.

Related Experiment Videos

  • Experimental studies on prostate cancer prevention and hair loss.

    • Main Results:

    • Significant improvements observed in men with enlarged prostates.
    • Emerging long-term data suggests potential arrest of BPH progression.
    • Positive outcomes in experimental models for prostate cancer prevention and male pattern baldness.

    Conclusions:

    • Finasteride effectively manages benign prostatic hyperplasia (BPH) with long-term benefits.
    • It offers promising therapeutic avenues for prostate cancer prevention.
    • Finasteride shows potential for treating male pattern baldness by inhibiting DHT.